QIAGEN NV Stock Rises on Positive Analyst Outlook and Molecular Diagnostics Growth
QIAGEN NV’s stock price has seen a moderate increase due to analysts’ optimistic views on the company’s prospects in the growing molecular diagnostics market.
One minute to read